Who is sponsoring NCT05613335?

NCT05613335 is sponsored by Mansoura University.

What drugs are being tested in NCT05613335?

Interventions in NCT05613335: Maxillary sinus augmentation using autologous fibrin glue with simultaneous implant placement, Maxillary sinus augmentation using mixture of autologous fibrin glue with bone graft with simultaneous implant placement.

What condition does NCT05613335 study?

NCT05613335 studies Missed Upper Posterior Teeth.

Is NCT05613335 still recruiting?

NCT05613335 is currently status unknown. Last updated 14 November 2022.

Last reviewed 2022-11-14 · How we verify

NCT05613335

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Crestal Sinus Technique Using Autologous Fibrin Glue Vs Sticky Bone With Simultaneous Implant Insertion.

Status unknown NA Last updated 14 November 2022

What this trial tests

NA trial testing Maxillary sinus augmentation using autologous fibrin glue with simultaneous implant placement in Missed Upper Posterior Teeth in 10 participants. Status unknown.

Timeline

18 October 2020

Primary endpoint
10 February 2022

10 November 2022

Quick facts

Lead sponsor	Mansoura University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	18 October 2020
Primary completion	10 February 2022
Estimated completion	10 November 2022
Sites	1 location across Egypt

Drugs / interventions tested

Maxillary sinus augmentation using autologous fibrin glue with simultaneous implant placement
Maxillary sinus augmentation using mixture of autologous fibrin glue with bone graft with simultaneous implant placement

Conditions studied

Missed Upper Posterior Teeth — all drugs for Missed Upper Posterior Teeth →

Sponsor

Mansoura University

Who can join

Adults 18 to 55, any sex, with Missed Upper Posterior Teeth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

prospective comparison of minimal Invasive Crestal Sinus Technique Using Autologous Fibrin Glue Vs Sticky Bone with simultaneous implant insertion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05613335 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 14 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05613335.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing